Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice - PubMed (original) (raw)
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
R Z Chen et al. Nat Genet. 2001 Mar.
Abstract
Mecp2 is an X-linked gene encoding a nuclear protein that binds specifically to methylated DNA (ref. 1) and functions as a general transcriptional repressor by associating with chromatin-remodeling complexes. Mecp2 is expressed at high levels in the postnatal brain, indicating that methylation-dependent regulation of gene expression may have a crucial role in the mammalian central nervous system. Consistent with this notion is the recent demonstration that MECP2 mutations cause Rett syndrome (RTT, MIM 312750), a childhood neurological disorder that represents one of the most common causes of mental retardation in females. Here we show that Mecp2-deficient mice exhibit phenotypes that resemble some of the symptoms of RTT patients. Mecp2-null mice were normal until 5 weeks of age, when they began to develop disease, leading to death between 6 and 12 weeks. Mutant brains showed substantial reduction in both weight and neuronal cell size, but no obvious structural defects or signs of neurodegeneration. Brain-specific deletion of Mecp2 at embryonic day (E) 12 resulted in a phenotype identical to that of the null mutation, indicating that the phenotype is caused by Mecp2 deficiency in the CNS rather than in peripheral tissues. Deletion of Mecp2 in postnatal CNS neurons led to a similar neuronal phenotype, although at a later age. Our results indicate that the role of Mecp2 is not restricted to the immature brain, but becomes critical in mature neurons. Mecp2 deficiency in these neurons is sufficient to cause neuronal dysfunction with symptomatic manifestation similar to Rett syndrome.
Similar articles
- Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
LaSalle JM, Goldstine J, Balmer D, Greco CM. LaSalle JM, et al. Hum Mol Genet. 2001 Aug 15;10(17):1729-40. doi: 10.1093/hmg/10.17.1729. Hum Mol Genet. 2001. PMID: 11532982 - Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
Luikenhuis S, Giacometti E, Beard CF, Jaenisch R. Luikenhuis S, et al. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6033-8. doi: 10.1073/pnas.0401626101. Epub 2004 Apr 6. Proc Natl Acad Sci U S A. 2004. PMID: 15069197 Free PMC article. - The neurobiology of Rett syndrome.
Akbarian S. Akbarian S. Neuroscientist. 2003 Feb;9(1):57-63. doi: 10.1177/1073858402239591. Neuroscientist. 2003. PMID: 12580340 Review. - Rett syndrome: the complex nature of a monogenic disease.
Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F. Renieri A, et al. J Mol Med (Berl). 2003 Jun;81(6):346-54. doi: 10.1007/s00109-003-0444-9. Epub 2003 May 16. J Mol Med (Berl). 2003. PMID: 12750821 Review. - A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
Guy J, Hendrich B, Holmes M, Martin JE, Bird A. Guy J, et al. Nat Genet. 2001 Mar;27(3):322-6. doi: 10.1038/85899. Nat Genet. 2001. PMID: 11242117
Cited by
- Inhibition of miR-15a Promotes BDNF Expression and Rescues Dendritic Maturation Deficits in MeCP2-Deficient Neurons.
Gao Y, Su J, Guo W, Polich ED, Magyar DP, Xing Y, Li H, Smrt RD, Chang Q, Zhao X. Gao Y, et al. Stem Cells. 2015 May;33(5):1618-29. doi: 10.1002/stem.1950. Stem Cells. 2015. PMID: 25639236 Free PMC article. - Characterization of the MeCP2R168X knockin mouse model for Rett syndrome.
Wegener E, Brendel C, Fischer A, Hülsmann S, Gärtner J, Huppke P. Wegener E, et al. PLoS One. 2014 Dec 26;9(12):e115444. doi: 10.1371/journal.pone.0115444. eCollection 2014. PLoS One. 2014. PMID: 25541993 Free PMC article. - Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses.
Goffin D, Allen M, Zhang L, Amorim M, Wang IT, Reyes AR, Mercado-Berton A, Ong C, Cohen S, Hu L, Blendy JA, Carlson GC, Siegel SJ, Greenberg ME, Zhou Z. Goffin D, et al. Nat Neurosci. 2011 Nov 27;15(2):274-83. doi: 10.1038/nn.2997. Nat Neurosci. 2011. PMID: 22119903 Free PMC article. - Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development.
Itoh M, Tahimic CG, Ide S, Otsuki A, Sasaoka T, Noguchi S, Oshimura M, Goto Y, Kurimasa A. Itoh M, et al. J Biol Chem. 2012 Apr 20;287(17):13859-67. doi: 10.1074/jbc.M111.309864. Epub 2012 Feb 28. J Biol Chem. 2012. PMID: 22375006 Free PMC article. - Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain.
Stuss DP, Cheema M, Ng MK, Martinez de Paz A, Williamson B, Missiaen K, Cosman JD, McPhee D, Esteller M, Hendzel M, Delaney K, Ausió J. Stuss DP, et al. Nucleic Acids Res. 2013 May;41(9):4888-900. doi: 10.1093/nar/gkt213. Epub 2013 Apr 4. Nucleic Acids Res. 2013. PMID: 23558747 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases